Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 495 | 495 | 995 | 995 | 500 |
| Gross Profit | 495 | 495 | 995 | 995 | 500 |
| Operating Expenses | 10,447 | 22,522 | 3,949 | 17,408 | 17,880 |
| Operating Income | -9,953 | -22,028 | -2,954 | -16,413 | -17,380 |
| Interest Expense | 616 | 299 | 538 | 399 | 690 |
| Other Income | 0 | 0 | 0 | 0 | 20 |
| Pre-tax Income | -10,568 | -22,327 | -3,492 | -16,812 | -18,050 |
| Income Tax | 0 | 1 | 51 | 52 | 10 |
| Net Income Continuous | -10,568 | -22,327 | -3,542 | -16,864 | -18,060 |
| Minority Interests | N/A | N/A | N/A | N/A | -896 |
| Net Income | $-10,568 | $-22,327 | $-3,542 | $-16,864 | $-17,170 |
| EPS Basic Total Ops | -62.40 | -256.00 | -51.20 | -217.60 | -280.00 |
| EPS Basic Continuous Ops | -58.99 | -189.85 | -40.04 | -206.57 | -280.47 |
| EPS Diluted Total Ops | -62.40 | -256.00 | -51.20 | -217.60 | -280.00 |
| EPS Diluted Continuous Ops | -58.99 | -189.85 | -40.04 | -206.57 | -280.47 |
| EBITDA(a) | $-9,349 | $-21,429 | $-2,356 | $-15,819 | $-16,422 |